NCT00515541View on ClinicalTrials.gov

Lovaza's Effect on the Activation of Platelets

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Cardiovascular DiseaseBleeding
Interventions
DRUG

Lovaza

First 6 weeks period take 1 gram Lovaza capsule daily 2nd 6 weeks period take 2 grams of Lovaza (2 1 gram capsules) daily 3rd 6 weeks period take 4 grams of Lovaza (4 1 gram capsules) daily 4th 6 weeks period take 8 grams of Lovaza (8 1 gram capsules) daily

Sponsors

Lead Sponsor

Invitrox
All Listed Sponsors
collaborator

Reliant Pharmaceuticals

INDUSTRY

lead

Invitrox

INDUSTRY

NCT00515541 - Lovaza's Effect on the Activation of Platelets | Biotech Hunter | Biotech Hunter